Nessan Bermingham

2016

In 2016, Nessan Bermingham earned a total compensation of $4M as President and Chief Executive Officer at Intellia Therapeutics, a 613% increase compared to previous year.

Compensation breakdown

Bonus$225,000
Option Awards$3,338,330
Salary$450,000
Other$718
Total$4,014,048

Bermingham received $3.3M in option awards, accounting for 83% of the total pay in 2016.

Bermingham also received $225K in bonus, $450K in salary and $718 in other compensation.

Rankings

In 2016, Nessan Bermingham's compensation ranked 2,224th out of 14,075 executives tracked by ExecPay. In other words, Bermingham earned more than 84.2% of executives.

ClassificationRankingPercentile
All
2,224
out of 14,075
84th
Division
Manufacturing
774
out of 5,488
86th
Major group
Chemicals And Allied Products
225
out of 1,900
88th
Industry group
Drugs
163
out of 1,543
89th
Industry
In Vitro and In Vivo Diagnostic Substances
4
out of 65
94th
Source: SEC filing on April 18, 2017.

Bermingham's colleagues

We found two more compensation records of executives who worked with Nessan Bermingham at Intellia Therapeutics in 2016.

2016

John Leonard

Intellia Therapeutics

Executive Vice President, Research & Development

2016

José Rivera

Intellia Therapeutics

General Counsel

In-depth

You may also like